Nyxoah SA Stock News
$6.95
6.92%
today
Nasdaq,
Apr 03, 05:14 pm CET
Nyxoah SA Stock News
Neutral
GlobeNewsWire
●
3 days ago
Investors can contact the law firm at no cost to learn more about recovering their losses
Neutral
GlobeNewsWire
●
8 days ago
INSIDE INFORMATION REGULATED INFORMATION FDA Issues Nyxoah an Approvable Letter for its Genio® System Mont-Saint-Guibert, Belgium – March 26, 2025, 8:00am CET / 3:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the U.S. Food and Drug...
AD HOC NEWS
●
9 days ago
Nyxoah SA. / BE0974358906
AD HOC NEWS
●
9 days ago
Nyxoah SA. / BE0974358906
Neutral
Seeking Alpha
●
21 days ago
Nyxoah SA (NASDAQ:NYXH ) Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ET Company Participants John Landry - Chief Financial Officer Olivier Taelman - CEO Conference Call Participants Adam Maeder - Piper Sandler Jon Block - Stifel Matthew Park - Cantor Fitzgerald Suraj Kalia - Oppenheimer & Co. David Rescott - Baird Paige Chamberlain - Wolfe Research Operator Hello, and welcome to Nyx...
Neutral
GlobeNewsWire
●
21 days ago
REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Financial Year 202 4 Financial and Operating Results FDA PMA Application Review Nearing Conclusion Positioned for U.S. Commercial Launch in March 2025 Mont-Saint-Guibert, Belgium – March 1 3 , 2024 , 7 : 0 0 am CET / 2 : 0 0 am ET – Nyxoah SA ( Euronext Brussels/Nasdaq : NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatm...
AD HOC NEWS
●
22 days ago
Nyxoah SA. / BE0974358906
Neutral
GlobeNewsWire
●
24 days ago
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
